Equities

Japan Hospice Holdings Inc

7061:TYO

Japan Hospice Holdings Inc

Actions
Health CareHealth Care Providers
  • Price (JPY)1,351.00
  • Today's Change-10.00 / -0.73%
  • Shares traded83.70k
  • 1 Year change-44.10%
  • Beta1.3722
Data delayed at least 20 minutes, as of Nov 26 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in JPY

The one analyst offering a 12 month price target expects Japan Hospice Holdings Inc share price to rise to 2,600.00 in the next year from the last price of 1,351.00.
High92.5%2,600.00
Med92.5%2,600.00
Low92.5%2,600.00

Earnings history & estimates in JPY

Japan Hospice Holdings Inc reported annual 2023 earnings of 84.81 per share on Feb 13, 2024.
Average growth rate+48.28%
More ▼

Revenue history & estimates in JPY

Japan Hospice Holdings Inc. had 3rd quarter 2024 revenues of 3.19m. This missed the 3.27m estimate of the one analyst following the company. This was 42.23% above the prior year's 3rd quarter results.
Average growth rate+5.59%
Japan Hospice Holdings Inc. had revenues for the full year 2023 of 9.87m. This was 25.04% above the prior year's results.
Average growth rate+23.97%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.